贝伐单抗治疗遗传性出血性毛细血管扩张症中的复杂性肝血管畸形：一则警示 - Suppr

Suppr

超能文献

Bevacizumab to treat complicated liver vascular malformations in hereditary hemorrhagic telangiectasia: a word of caution.

作者信息

Buscarini Elisabetta, Manfredi Guido, Zambelli Alessandro

出版信息

Liver Transpl. 2008 Nov;14(11):1685-6; author reply 1687-8. doi: 10.1002/lt.21656.

DOI:10.1002/lt.21656

PMID:18975280

Abstract

摘要

相似文献

Bevacizumab to treat complicated liver vascular malformations in hereditary hemorrhagic telangiectasia: a word of caution.贝伐单抗治疗遗传性出血性毛细血管扩张症中的复杂性肝血管畸形：一则警示

Liver Transpl. 2008 Nov;14(11):1685-6; author reply 1687-8. doi: 10.1002/lt.21656.

Bevacizumab reverses need for liver transplantation in hereditary hemorrhagic telangiectasia.贝伐单抗可逆转遗传性出血性毛细血管扩张症患者对肝移植的需求。

Liver Transpl. 2008 Feb;14(2):210-3. doi: 10.1002/lt.21417.

More on bevacizumab in hereditary hemorrhagic telangiectasia.贝伐单抗治疗遗传性出血性毛细血管扩张症的更多研究

N Engl J Med. 2009 Aug 27;361(9):931; author reply 931-2.

More on bevacizumab in hereditary hemorrhagic telangiectasia.关于贝伐单抗在遗传性出血性毛细血管扩张症中的更多信息。

N Engl J Med. 2009 Aug 27;361(9):931; author reply 931-2. doi: 10.1056/NEJMc091271.

Long-term therapy with bevacizumab in hereditary hemorrhagic telangiectasia.贝伐单抗用于遗传性出血性毛细血管扩张症的长期治疗。

N Engl J Med. 2011 Feb 17;364(7):688-9. doi: 10.1056/NEJMc1012774.

Low dose intravenous bevacizumab for the treatment of anaemia in hereditary haemorrhagic telangiectasia.低剂量静脉注射贝伐单抗治疗遗传性出血性毛细血管扩张症贫血

Br J Haematol. 2011 Feb;152(4):365. doi: 10.1111/j.1365-2141.2010.08481.x. Epub 2010 Dec 1.

[Thalidomide: new therapeutic indications?].

Rev Med Suisse. 2010 Apr 21;6(245):846-7.

Bevacizumab in hereditary hemorrhagic telangiectasia.贝伐单抗治疗遗传性出血性毛细血管扩张症。

N Engl J Med. 2009 May 14;360(20):2143-4. doi: 10.1056/NEJMc0901421.

Bevacizumab: finding its niche in the treatment of heart failure secondary to liver vascular malformations in hereditary hemorrhagic telangiectasia.贝伐单抗：在遗传性出血性毛细血管扩张症所致肝血管畸形继发心力衰竭的治疗中找到其用武之地。

Hepatology. 2013 Jul;58(1):442-5. doi: 10.1002/hep.26472. Epub 2013 May 31.

Bevacizumab treatment in multifocal lymphangioendotheliomatosis with thrombocytopenia.贝伐单抗治疗伴血小板减少的多灶性淋巴管内皮瘤病。

Pediatr Blood Cancer. 2009 Apr;52(4):534-6. doi: 10.1002/pbc.21860.

引用本文的文献

Perioperative Complications and Long-Term Follow-Up of Liver Transplantation in Hemorrhagic Hereditary Telangiectasia: Report of Three Cases and Systematic Review.出血性遗传性毛细血管扩张症患者肝移植的围手术期并发症及长期随访：三例报告及系统评价

J Clin Med. 2022 Sep 24;11(19):5624. doi: 10.3390/jcm11195624.

High output cardiac failure in 3 patients with hereditary hemorrhagic telangiectasia and hepatic vascular malformations, evaluation of treatment.遗传性出血性毛细血管扩张症伴肝血管畸形 3 例高输出量心力衰竭，治疗评估。

Orphanet J Rare Dis. 2020 Nov 26;15(1):334. doi: 10.1186/s13023-020-01583-6.

Bevacizumab treatment in hereditary hemorrhagic teleangiectasia.

Eur J Clin Pharmacol. 2012 Dec;68(12):1685-6. doi: 10.1007/s00228-012-1308-4. Epub 2012 May 30.

Natural history and outcome of hepatic vascular malformations in a large cohort of patients with hereditary hemorrhagic teleangiectasia.遗传性出血性毛细血管扩张症患者大队列中肝血管畸形的自然史和结局。

Dig Dis Sci. 2011 Jul;56(7):2166-78. doi: 10.1007/s10620-011-1585-2. Epub 2011 Feb 3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验